{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:21:03Z","timestamp":1778707263853,"version":"3.51.4"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T00:00:00Z","timestamp":1548201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Gambl Stud"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1007\/s10899-019-09828-1","type":"journal-article","created":{"date-parts":[[2019,1,24]],"date-time":"2019-01-24T05:12:37Z","timestamp":1548306757000},"page":"85-96","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Drugs-Induced Pathological Gambling: An Analysis of Italian Spontaneous Reporting System"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9216-922X","authenticated-orcid":false,"given":"Cristina","family":"Scavone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Stelitano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Concetta","family":"Rafaniello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liberata","family":"Sportiello","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annalisa","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,23]]},"reference":[{"key":"9828_CR1","unstructured":"Agenzia Italiana del Farmaco. Importanti informazioni sulla sicurezza riguardanti i farmaci dopamino agonisti. Available at: \nhttp:\/\/www.agenziafarmaco.gov.it\/wscs_render_attachment_by_id\/111.71353.11724881557268b10.pdf?id=111.71359.1172488156158\n\n. Accessed 5 June 2018."},{"key":"9828_CR2","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1080\/14740338.2017.1388371","volume":"16","author":"F Auricchio","year":"2017","unstructured":"Auricchio, F., Scavone, C., Cimmaruta, D., Di Mauro, G., Capuano, A., Sportiello, L., et al. (2017). Drugs approved for the treatment of multiple sclerosis: review of their safety profile. Expert Opinion on Drug Safety,16, 1359\u20131371.","journal-title":"Expert Opinion on Drug Safety"},{"key":"9828_CR3","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.psychres.2018.03.041","volume":"270","author":"M Balconi","year":"2018","unstructured":"Balconi, M., Angioletti, L., Siri, C., Meucci, N., & Pezzoli, G. (2018). Gambling behavior in Parkinson\u2019s disease: Impulsivity, reward mechanism and cortical brain oscillations. Psychiatry Research,270, 974\u2013980.","journal-title":"Psychiatry Research"},{"key":"9828_CR4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1345\/aph.18003","volume":"33","author":"JA Barone","year":"1999","unstructured":"Barone, J. A. (1999). Domperidone: a peripherally acting dopamine2-receptor antagonist. Annals of Pharmacotherapy,33, 429\u2013440.","journal-title":"Annals of Pharmacotherapy"},{"key":"9828_CR5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s40263-014-0221-z","volume":"29","author":"A Boyle","year":"2015","unstructured":"Boyle, A., & Ondo, W. (2015). Role of apomorphine in the treatment of Parkinson\u2019s disease. CNS Drugs,29, 83\u201389.","journal-title":"CNS Drugs"},{"key":"9828_CR6","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s10899-015-9576-4","volume":"32","author":"J Caballero","year":"2016","unstructured":"Caballero, J., Ownby, R. L., Rey, J. A., & Clauson, K. A. (2016). Cognitive and performance enhancing medication use to improve performance in poker. Journal of Gambling Studies,32, 835\u2013845.","journal-title":"Journal of Gambling Studies"},{"issue":"Suppl 1","key":"9828_CR7","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1517\/14740338.2014.941804","volume":"13","author":"A Capuano","year":"2014","unstructured":"Capuano, A., Scavone, C., Rafaniello, C., Arcieri, R., Rossi, F., & Panei, P. (2014). Atomoxetine in the treatment of attention deficit hyperactivity disorder and suicidal ideation. Expert Opinion on Drug Safety,13(Suppl 1), S69\u2013S78.","journal-title":"Expert Opinion on Drug Safety"},{"key":"9828_CR8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.2174\/157488611794480016","volume":"6","author":"J Cohen","year":"2011","unstructured":"Cohen, J., Magalon, D., Boyer, L., Simon, N., & Christophe, L. (2011). Aripiprazole-induced pathological gambling: A report of 3 cases. Current Drug Safety,6, 51\u201353.","journal-title":"Current Drug Safety"},{"key":"9828_CR9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/00008571-199606000-00004","volume":"6","author":"DE Comings","year":"1996","unstructured":"Comings, D. E., Rosenthal, R. J., Lesieur, H. R., Rugle, L. J., Muhleman, D., Chiu, C., et al. (1996). A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics,6, 223\u2013234.","journal-title":"Pharmacogenetics"},{"key":"9828_CR10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s10072-011-0605-5","volume":"32","author":"G d\u2019Orsi","year":"2011","unstructured":"d\u2019Orsi, G., Demaio, V., & Specchio, L. M. (2011). Pathological gambling plus hypersexuality in restless legs syndrome: A new case. Neurological Sciences,32, 707\u2013709.","journal-title":"Neurological Sciences"},{"key":"9828_CR33","unstructured":"DSM-5. Diagnostic criteria: Gambling disorder. Available at: \nhttp:\/\/www.ncpgambling.org\/wp-content\/uploads\/2014\/08\/DSM-5-Diagnostic-Criteria-Gambling-Disorder.pdf\n\n. Accessed 5 June 2018."},{"key":"9828_CR11","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1097\/JCP.0000000000000634","volume":"37","author":"M Etminan","year":"2017","unstructured":"Etminan, M., Sodhi, M., Samii, A., Procyshyn, R. M., Guo, M., & Carleton, B. C. (2017). Risk of Gambling disorder and impulse control disorder with aripiprazole, pramipexole, and ropinirole: A pharmacoepidemiologic study. Journal of Clinical Psychopharmacology,37, 102\u2013104.","journal-title":"Journal of Clinical Psychopharmacology"},{"key":"9828_CR12","unstructured":"Fisco. entrate record dal gioco d\u2019azzardo: in Europa nessuno come noi. Available at: \nhttp:\/\/www.today.it\/economia\/gettito-fiscale-giochi-scommesse-italia-dati.html\n\n. Accessed 5 June 2018."},{"key":"9828_CR13","first-page":"34","volume":"2","author":"TW Fong","year":"2005","unstructured":"Fong, T. W. (2005). The vulnerable faces of pathological gambling. Psychiatry (Edgmont),2, 34\u201342.","journal-title":"Psychiatry (Edgmont)"},{"key":"9828_CR14","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.addbeh.2013.11.005","volume":"39","author":"L Gaboriau","year":"2014","unstructured":"Gaboriau, L., Victorri-Vigneau, C., G\u00e9rardin, M., Allain-Veyrac, G., Jolliet-Evin, P., & Grall-Bronnec, M. (2014). Aripiprazole: a new risk factor for pathological gambling? A report of 8 case reports. Addictive Behaviors,39, 562\u2013565.","journal-title":"Addictive Behaviors"},{"key":"9828_CR15","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1055\/s-0031-1281580","volume":"79","author":"M Gahr","year":"2011","unstructured":"Gahr, M., Connemann, B. J., & Sch\u00f6nfeldt-Lecuona, C. J. (2011). Pathological gambling induced by dopamine agonists. Fortschritte der Neurologie-Psychiatrie,79, 470\u2013474.","journal-title":"Fortschritte der Neurologie-Psychiatrie"},{"key":"9828_CR16","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1111\/j.1556-4029.2010.01483.x","volume":"55","author":"G Gavaudan","year":"2010","unstructured":"Gavaudan, G., Magalon, D., Cohen, J., Lan\u00e7on, C., L\u00e9onetti, G., & P\u00e9lissier-Alicot, A. L. (2010). Partial agonist therapy in schizophrenia: Relevance to diminished criminal responsibility. Journal of Forensic Sciences,55, 1659\u20131662.","journal-title":"Journal of Forensic Sciences"},{"key":"9828_CR17","doi-asserted-by":"publisher","DOI":"10.4088\/PCC.14l01707","author":"WT George","year":"2015","unstructured":"George, W. T., Varghese, R., & Khawaja, I. S. (2015). New onset of compulsive gambling associated with modafinil: A case report. The Primary Care Companion for CNS Disorders. \nhttps:\/\/doi.org\/10.4088\/PCC.14l01707\n\n.","journal-title":"The Primary Care Companion for CNS Disorders"},{"key":"9828_CR18","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1192\/bjp.bp.114.154286","volume":"207","author":"L Jones","year":"2015","unstructured":"Jones, L., Metcalf, A., Gordon-Smith, K., Forty, L., Perry, A., Lloyd, J., et al. (2015). Gambling problems in bipolar disorder in the UK: Prevalence and distribution. The British Journal of Psychiatry.,207, 328\u2013333.","journal-title":"The British Journal of Psychiatry."},{"key":"9828_CR19","first-page":"603631","volume":"2012","author":"BJ Kelley","year":"2012","unstructured":"Kelley, B. J., Duker, A. P., & Chiu, P. (2012). Dopamine agonists and pathologic behaviors. Parkinson\u2019s Disease.,2012, 603631.","journal-title":"Parkinson\u2019s Disease."},{"key":"9828_CR20","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD006569.pub5","author":"P Khanna","year":"2014","unstructured":"Khanna, P., Suo, T., Komossa, K., Ma, H., Rummel-Kluge, C., El-Sayeh, H. G., et al. (2014). Aripiprazole versus other atypical antipsychotics for schizophrenia. The Cochrane Database of Systematic Reviews. \nhttps:\/\/doi.org\/10.1002\/14651858.CD006569.pub5\n\n.","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"9828_CR21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0033-3182(10)70695-2","volume":"5","author":"BP Kolla","year":"2010","unstructured":"Kolla, B. P., Mansukhani, M. P., Barraza, R., & Bostwick, J. M. (2010). Impact of dopamine agonists on compulsive behaviors: A case series of pramipexole-induced pathological gambling. Psychosomatics,5, 271\u2013273.","journal-title":"Psychosomatics"},{"key":"9828_CR22","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00702-015-1449-6","volume":"122","author":"M Kuoppam\u00e4ki","year":"2015","unstructured":"Kuoppam\u00e4ki, M., Leinonen, M., & Poewe, W. (2015). Efficacy and safety of entacapone in levodopa\/carbidopa versus levodopa\/benserazide treated Parkinson\u2019s disease patients with wearing-off. Journal of Neural Transmission,122, 1709\u20131714.","journal-title":"Journal of Neural Transmission"},{"key":"9828_CR23","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1002\/mds.21057","volume":"21","author":"AJ Larner","year":"2006","unstructured":"Larner, A. J. (2006). Medical hazards of the internet: Gambling in Parkinson\u2019s disease. Movement Disorders,21, 1789.","journal-title":"Movement Disorders"},{"key":"9828_CR24","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.pharmthera.2016.06.007","volume":"165","author":"GM Leggio","year":"2016","unstructured":"Leggio, G. M., Bucolo, C., Platania, C. B., Salomone, S., & Drago, F. (2016). Current drug treatments targeting dopamine D3 receptor. Pharmacology & Therapeutics,165, 164\u2013177.","journal-title":"Pharmacology & Therapeutics"},{"key":"9828_CR25","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/mds.26082","volume":"30","author":"PA LeWitt","year":"2015","unstructured":"LeWitt, P. A. (2015). Levodopa therapy for Parkinson\u2019s disease: Pharmacokinetics and pharmacodynamics. Movement Disorders,30, 64\u201372.","journal-title":"Movement Disorders"},{"key":"9828_CR26","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1038\/npp.2016.265","volume":"42","author":"J Majuri","year":"2017","unstructured":"Majuri, J., Joutsa, J., Johansson, J., Voon, V., Alakurtti, K., Parkkola, R., et al. (2017). Dopamine and opioid neurotransmission in behavioral addictions: A comparative PET Study in pathological gambling and binge eating. Neuropsychopharmacology,42, 1169\u20131177.","journal-title":"Neuropsychopharmacology"},{"key":"9828_CR27","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/j.psychres.2014.11.011","volume":"225","author":"V Manning","year":"2015","unstructured":"Manning, V., Koh, P. K., Yang, Y., Ng, A., Guo, S., Kandasami, G., et al. (2015). Suicidal ideation and lifetime attempts in substance and gambling disorders. Psychiatry Research,225, 706\u2013709.","journal-title":"Psychiatry Research"},{"key":"9828_CR28","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.phrs.2017.07.005","volume":"123","author":"A Mascolo","year":"2017","unstructured":"Mascolo, A., Scavone, C., Sessa, M., di Mauro, G., Cimmaruta, D., Orlando, V., et al. (2017). Can causality assessment fulfill the new European definition of adverse drug reaction? A review of methods used in spontaneous reporting. Pharmacological Research,123, 122\u2013129.","journal-title":"Pharmacological Research"},{"key":"9828_CR29","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.4103\/0976-500X.120942","volume":"4","author":"C Mazzitello","year":"2013","unstructured":"Mazzitello, C., Esposito, S., De Francesco, A. E., Capuano, A., Russo, E., & De Sarro, G. (2013). Pharmacovigilance in Italy: An overview. Journal of Pharmacology & Pharmacotherapeutics,4, S20\u2013S28.","journal-title":"Journal of Pharmacology & Pharmacotherapeutics"},{"key":"9828_CR30","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.encep.2016.01.003","volume":"42","author":"D M\u00e9t\u00e9","year":"2016","unstructured":"M\u00e9t\u00e9, D., Dafreville, C., Paitel, V., & Wind, P. (2016). Aripiprazole, gambling disorder and compulsive sexuality. Encephale,42, 281\u2013283.","journal-title":"Encephale"},{"key":"9828_CR31","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","volume":"174","author":"TJ Moore","year":"2014","unstructured":"Moore, T. J., Glenmullen, J., & Mattison, D. R. (2014). Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Internal Medicine,174, 1930\u20131933.","journal-title":"JAMA Internal Medicine"},{"key":"9828_CR32","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo, C. A., Busto, U., Sellers, E. M., Sandor, P., Ruiz, I., Roberts, E. A., et al. (1981). A method for estimating the probability of adverse drug reactions. Clinical Pharmacology Therapeutics,30, 239\u2013245.","journal-title":"Clinical Pharmacology Therapeutics"},{"key":"9828_CR34","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1177\/1039856217715996","volume":"25","author":"E Peterson","year":"2017","unstructured":"Peterson, E., & Forlano, R. (2017). Partial dopamine agonist-induced pathological gambling and impulse-control deficit on low-dose aripiprazole. Australasian Psychiatry,25, 614\u2013616.","journal-title":"Australasian Psychiatry"},{"key":"9828_CR35","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3389\/fpsyt.2012.00102","volume":"3","author":"M Pettorruso","year":"2012","unstructured":"Pettorruso, M., Martinotti, G., Di Nicola, M., Onofrj, M., Di Giannantonio, M., Conte, G., et al. (2012). Amantadine in the treatment of pathological gambling: A case report. Frontiers in Psychiatry,3, 102.","journal-title":"Frontiers in Psychiatry"},{"key":"9828_CR36","unstructured":"PhVWP monthly report on safety concerns, guidelines and general matters. \nhttp:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Report\/2012\/07\/WC500130391.pdf\n\n. Accessed 5 June 2018."},{"key":"9828_CR37","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.euroneuro.2014.11.006","volume":"25","author":"F Pontieri","year":"2015","unstructured":"Pontieri, F., Assogna, F., Pellicano, C., Cacciari, C., Pannunzi, S., Morrone, A., et al. (2015). Sociodemographic, neuropsychiatric and cognitive characteristics of pathological gambling and impulse control disorders NOS in Parkinson\u2019s disease. European Neuropsychopharmacology,25, 69\u201376.","journal-title":"European Neuropsychopharmacology"},{"key":"9828_CR38","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1046\/j.1525-1497.2002.10812.x","volume":"17","author":"MN Potenza","year":"2002","unstructured":"Potenza, M. N., Fiellin, D. A., Heninger, G. R., Rounsaville, B. J., & Mazure, C. M. (2002). Gambling: An addictive behavior with health and primary care implications. Journal of General Internal Medicine,17, 721\u2013732.","journal-title":"Journal of General Internal Medicine"},{"key":"9828_CR39","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.pnpbp.2004.06.015","volume":"28","author":"R Ramasubbu","year":"2004","unstructured":"Ramasubbu, R. (2004). Antidepressant treatment-associated behavioural expression of hypomania: A case series. Progress in Neuropsychopharmacology and Biological Psychiatry,28, 1201\u20131207.","journal-title":"Progress in Neuropsychopharmacology and Biological Psychiatry"},{"key":"9828_CR40","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.parkreldis.2013.02.007","volume":"19","author":"G Santangelo","year":"2013","unstructured":"Santangelo, G., Barone, P., Trojano, L., & Vitale, C. (2013). Pathological gambling in Parkinson\u2019s disease. A comprehensive review. Parkinsonism & Related Disorders,19, 645\u2013653.","journal-title":"Parkinsonism & Related Disorders"},{"key":"9828_CR41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3389\/fphar.2017.00607","volume":"8","author":"C Scavone","year":"2017","unstructured":"Scavone, C., Sportiello, L., Sullo, M. G., Ferrajolo, C., Ruggiero, R., Sessa, M., et al. (2017). Safety profile of anticancer and immune-modulating biotech drugs used in a real world setting in Campania Region (Italy): BIO-Cam observational study. Frontiers in Pharmacology.,8, 607.","journal-title":"Frontiers in Pharmacology."},{"key":"9828_CR42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.parkreldis.2011.10.010","volume":"18","author":"SR Schreglmann","year":"2012","unstructured":"Schreglmann, S. R., Gantenbein, A. R., Eisele, G., & Baumann, C. R. (2012). Transdermal rotigotine causes impulse control disorders in patients with restless legs syndrome. Parkinsonism & Related Disorders,18, 207\u2013209.","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"9828_CR43","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/1520-6394(2000)11:4<185::AID-DA8>3.0.CO;2-H","volume":"11","author":"S Seedat","year":"2000","unstructured":"Seedat, S., Kesler, S., Niehaus, D. J., & Stein, D. J. (2000). Pathological gambling behaviour: emergence secondary to treatment of Parkinson\u2019s disease with dopaminergic agents. Depression and Anxiety,11(4), 185\u2013186.","journal-title":"Depression and Anxiety"},{"key":"9828_CR44","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1002\/syn.21805","volume":"69","author":"P Seeman","year":"2015","unstructured":"Seeman, P. (2015). Parkinson\u2019s disease treatment may cause impulse-control disorder via dopamine D3 receptors. Synapse (New York, N. Y.),69, 183\u2013189.","journal-title":"Synapse (New York, N. Y.)"},{"key":"9828_CR45","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14740338.2016.1221397","volume":"15","author":"M Sessa","year":"2016","unstructured":"Sessa, M., Rafaniello, C., Sportiello, L., Mascolo, A., Scavone, C., Maccariello, A., et al. (2016a). Campania Region (Italy) spontaneous reporting system and preventability assessment through a case-by-case approach: A pilot study on psychotropic drugs. Expert Opinion on Drug Safety.,15, 9\u201315.","journal-title":"Expert Opinion on Drug Safety."},{"key":"9828_CR46","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/14740338.2016.1226280","volume":"15","author":"M Sessa","year":"2016","unstructured":"Sessa, M., Rossi, C., Rafaniello, C., Mascolo, A., Cimmaruta, D., Scavone, C., et al. (2016b). Campania preventability assessment committee: a focus on the preventability of the contrast media adverse drug reactions. Expert Opinion on Drug Safety,15, 51\u201359.","journal-title":"Expert Opinion on Drug Safety"},{"key":"9828_CR47","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1192\/bjp.bp.110.084996","volume":"199","author":"N Smith","year":"2011","unstructured":"Smith, N., Kitchenham, N., & Bowden-Jones, H. (2011). Pathological gambling and the treatment of psychosis with aripiprazole: Case reports. British Journal of Psychiatry,199, 158\u2013159.","journal-title":"British Journal of Psychiatry"},{"key":"9828_CR48","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1517\/14740338.2014.870152","volume":"13","author":"F Stocchi","year":"2014","unstructured":"Stocchi, F., Radicati, F. G., & Torti, M. (2014). Drug safety evaluation of ropinirole prolonged release. Expert Opinion on Drug Safety,13, 383\u2013389.","journal-title":"Expert Opinion on Drug Safety"},{"key":"9828_CR49","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.1176\/appi.neuropsych.23.1.E2","volume":"23","author":"SA Strejilevich","year":"2011","unstructured":"Strejilevich, S. A., Martino, D. J., Igoa, A., & Manes, F. (2011). Pathological gambling in a bipolar patient treated with pramipexole. The Journal of Neuropsychiatry and Clinical Neurosciences,23, E2\u2013E3.","journal-title":"The Journal of Neuropsychiatry and Clinical Neurosciences"},{"key":"9828_CR50","doi-asserted-by":"crossref","first-page":"e68177","DOI":"10.1371\/journal.pone.0068177","volume":"8","author":"M Symmonds","year":"2013","unstructured":"Symmonds, M., Wright, N. D., Fagan, E., & Dolan, R. J. (2013). Assaying the effect of levodopa on the evaluation of risk in healthy humans. PLoS ONE,8, e68177.","journal-title":"PLoS ONE"},{"key":"9828_CR51","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1002\/ana.22029","volume":"68","author":"A Thomas","year":"2010","unstructured":"Thomas, A., Bonnani, L., Gambi, F., Di Iorio, A., & Onofrj, M. (2010). Pathological gambling in Parkinson disease is reduced by amantadine. Annals of Neurology,68, 400\u2013404.","journal-title":"Annals of Neurology"},{"key":"9828_CR52","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1212\/WNL.0b013e3181fc27fa","volume":"75","author":"T Eimeren van","year":"2010","unstructured":"van Eimeren, T., Pellecchia, G., Cilia, R., Ballanger, B., Steeves, T. D., Houle, S., et al. (2010). Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology,75, 1711\u20131716.","journal-title":"Neurology"},{"key":"9828_CR53","doi-asserted-by":"crossref","first-page":"1750","DOI":"10.1212\/01.wnl.0000218206.20920.4d","volume":"66","author":"V Voon","year":"2006","unstructured":"Voon, V., Hassan, K., Zurowski, M., Duff-Canning, S., de Souza, M., Fox, S., et al. (2006). Prospective prevalence of pathological gambling and medication association in Parkinson disease. Neurology.,66, 1750\u20131752.","journal-title":"Neurology."},{"key":"9828_CR54","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/bs.irn.2017.04.006","volume":"133","author":"D Weintraub","year":"2017","unstructured":"Weintraub, D., & Claassen, D. O. (2017). Impulse control and related disorders in Parkinson\u2019s disease. International Review of Neurobiology,133, 679\u2013717.","journal-title":"International Review of Neurobiology"},{"key":"9828_CR55","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub, D., Koester, J., Potenza, M. N., Siderowf, A. D., Stacy, M., Voon, V., et al. (2010). Impulse control disorders in Parkinson disease: A cross-sectional study of 3090 patients. Archives of Neurology,67, 589\u2013595.","journal-title":"Archives of Neurology"},{"key":"9828_CR56","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/WNF.0b013e3181684542","volume":"32","author":"TS Wingo","year":"2009","unstructured":"Wingo, T. S., Evatt, M., Scott, B., Freeman, A., & Stacy, M. (2009). Impulse control disorders arising in 3 patients treated with rotigotine. Clinical Neuropharmacology,32, 59\u201362.","journal-title":"Clinical Neuropharmacology"},{"key":"9828_CR57","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/bph.12988","volume":"172","author":"M Wood","year":"2015","unstructured":"Wood, M., Dubois, V., Scheller, D., & Gillard, M. (2015). Rotigotine is a potent agonist at dopamine D1 receptors as well as at dopamine D2 and D3 receptors. British Journal of Pharmacology,172, 1124\u20131135.","journal-title":"British Journal of Pharmacology"}],"container-title":["Journal of Gambling Studies"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10899-019-09828-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10899-019-09828-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10899-019-09828-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,17]],"date-time":"2020-02-17T02:10:08Z","timestamp":1581905408000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10899-019-09828-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,23]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["9828"],"URL":"https:\/\/doi.org\/10.1007\/s10899-019-09828-1","relation":{},"ISSN":["1573-3602"],"issn-type":[{"value":"1573-3602","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,23]]},"assertion":[{"value":"23 January 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}